Invitris YC Application
Invitris went through Y Combinator in the Winter 2023 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2023
- Industry
- HealthcareDrug Discovery and Delivery
- Team size
- 6
- Status
- Active
- Launched
- 2023
Founders
Patrick GrossmannFounder
Kilian VogeleFounder
What Invitris does
Invitris radically simplifies how we create novel biological drugs. Our patent-pending technology platform turns DNA into synthetic proteins and was recently featured in the Science magazine. It makes creating new drugs >10,000x more efficient at <100x lower costs of material. Our killer application is enabling the newest generation of synthetic bacteriophages to combat antibiotic-resistant infections, which are threatening to cause more deaths than all cancers combined.
Invitris's YC application, reconstructed
Y Combinator application
Invitris, Winter 2023 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Invitris
Creating new protein-based drugs at scale
We're building a platform that turns DNA into synthetic proteins to create new biological drugs. It makes designing and producing proteins more than 10,000 times more efficient and cuts material costs by over 100 times compared to traditional methods. Our first focus is synthetic bacteriophages to fight antibiotic-resistant infections, which are causing more deaths than all cancers combined.
We live and operate in Munich, Bavaria, Germany. After YC, we would continue to base the company here.
We're based in Munich because that's where we have access to our core team and labs, and Germany has a strong biotech ecosystem that supports our work.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Invitris YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Invitris's public data (launch notes, founder backgrounds, product description). It shows how a company like Invitris would present itself to YC, not the text they submitted.
What YC batch was Invitris in?
Invitris was part of the Y Combinator Winter 2023 batch.
Who founded Invitris?
Invitris was founded by Patrick Grossmann, Kilian Vogele.
What does Invitris do?
Creating new protein-based drugs at scale
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Invitris's application, and every other YC batch, is in YC Insights.
